3-iodobenzylguanidine has been researched along with Behavior Disorder, Rapid Eye Movement Sleep in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (22.22) | 29.6817 |
2010's | 16 (44.44) | 24.3611 |
2020's | 12 (33.33) | 2.80 |
Authors | Studies |
---|---|
An, YS; Chang, J; Kim, JW; Park, DG; Yoon, JH | 1 |
Booij, J; Geibl, FF; Janzen, A; Kogan, RV; Leenders, KL; Luster, M; Mayer, G; Meles, SK; Oertel, WH; Renken, RJ; Sittig, E; Stormezand, G | 1 |
Booij, J; Geibl, F; Habibi, M; Henrich, MT; Janzen, A; Librizzi, D; Luster, M; Mayer, G; Oertel, W; Sittig, E; Timmermann, L; Vadasz, D | 1 |
Andersen, KB; Beier, CP; Borghammer, P; Fedorova, TD; Horsager, J; Knudsen, K; Otto, M; Skjærbæk, C; Sommerauer, M; Svendsen, KB | 1 |
Hanakawa, T; Hatano, K; Hatano, T; Hattori, N; Hayashi, T; Ikenaka, K; Ikeuchi, T; Inoue, Y; Iwaki, H; Kadotani, H; Kajiyama, Y; Kamei, Y; Kawabata, K; Matsuda, H; Mochizuki, H; Mukai, Y; Murata, M; Nakamura, T; Nishikawa, N; Saitoh, Y; Sakamoto, T; Sawamoto, N; Shimo, Y; Sumi, Y; Tachimori, H; Takahashi, R; Takahashi, Y; Taruno, Y; Watanabe, H | 1 |
An, YS; Kim, MS; Park, DG; Yoon, JH | 1 |
An, YS; Chang, J; Kim, JY; Kim, MH; Kim, MS; Park, DG; Yoon, JH | 1 |
Carli, G; Janzen, A; Kogan, RV; Leenders, KL; Meles, SK; Oertel, WH; Perani, D; Sittig, E | 1 |
Hayashi, H; Iseki, C; Ishizawa, K; Kawakatsu, S; Kobayashi, R; Morioka, D; Otani, K | 1 |
Hamano, T; Tachibana, N; Tsukita, K | 1 |
Garg, D | 1 |
Fujishiro, H; Fukui, T; Hieda, S; Ito, T; Nagahama, Y; Ota, K; Suga, H; Yamagata, M | 1 |
Orimo, S | 1 |
Fujishiro, H; Iritani, S; Iwamoto, K; Miyata, S; Okuda, M; Ozaki, N; Torii, Y | 1 |
Barateau, L; Benkiran, M; Chenini, S; Dauvilliers, Y; Evangelista, E; Jaussent, I; Lopez, R; Mariano-Goulart, D | 1 |
Berg, D; Postuma, RB | 1 |
Fujii, Y; Ohi, M; Okura, M; Taniguchi, M; Uemori, H | 1 |
Inaoka, T; Kishi, M; Sakakibara, R; Tateno, F; Terada, H; Tsuyusaki, Y | 1 |
Kim, JS; Lee, KS; Lee, SH; Oh, YS; Park, HE; Park, JW; Son, BC | 1 |
Choi, HS; Jung, YA; Kim, JS; Lee, KS; Lee, PH; Oh, YS; Park, HE; Park, IS; Ryu, DW; Song, IU; Yoo, IR | 1 |
Hirata, K; Iwanami, M; Miyamoto, M; Miyamoto, T; Nishibayashi, M; Suzuki, K | 1 |
Hirata, K; Ikematsu, A; Inoue, Y; Miyamoto, M; Miyamoto, T; Suzuki, K; Usui, Y | 1 |
Mahowald, MW; Schenck, CH | 1 |
Hirata, K; Iwanami, M; Miyamoto, M; Miyamoto, T | 3 |
Imamura, T; Kashihara, K; Shinya, T | 1 |
Abe, T; Högl, B; Inoue, Y; Kitayama, M; Miyoshi, H; Nakashima, K; Nomura, T; Uemura, Y | 1 |
Arai, H; Fujishiro, H; Higashi, S; Iseki, E; Kasanuki, K; Murayama, N; Sato, K; Suzuki, M; Yamamoto, R | 1 |
Högl, B; Inoue, Y; Nakashima, K; Nomura, T | 1 |
Gambardella, A; Labate, A; Morelli, M; Novellino, F; Quattrone, A; Salsone, M; Sturniolo, M | 1 |
Labate, A; Quattrone, A; Salsone, M | 1 |
Imamura, T; Kashihara, K | 1 |
Hirata, K; Inoue, Y; Miyamoto, M; Miyamoto, T; Suzuki, K; Usui, Y | 1 |
Homma, I; Kawamura, M; Koyama, S; Masaoka, Y; Tachibana, N | 1 |
Fukuyama, H; Kawanishi, T; Mitake, S; Oguri, T; Tachibana, N | 1 |
3 review(s) available for 3-iodobenzylguanidine and Behavior Disorder, Rapid Eye Movement Sleep
Article | Year |
---|---|
New development of diagnosis and treatment for Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Antiparkinson Agents; Cell- and Tissue-Based Therapy; Deep Brain Stimulation; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Electric Stimulation Therapy; Genetic Therapy; Humans; Magnetic Resonance Imaging; Myocardial Perfusion Imaging; Neuroimaging; Olfaction Disorders; Parkinson Disease; Radionuclide Imaging; REM Sleep Behavior Disorder; Substantia Nigra; Ultrasonography | 2017 |
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders | 2019 |
MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.
Topics: 3-Iodobenzylguanidine; Animals; Constipation; Humans; Hypotension, Orthostatic; Memory Disorders; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2014 |
2 trial(s) available for 3-iodobenzylguanidine and Behavior Disorder, Rapid Eye Movement Sleep
Article | Year |
---|---|
Comparison of severity of obstructive sleep apnea and degree of accumulation of cardiac 123I-MIBG radioactivity as a diagnostic marker for idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Polysomnography; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Respiratory Function Tests; Severity of Illness Index; Sleep Apnea, Obstructive | 2009 |
Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Humans; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2006 |
31 other study(ies) available for 3-iodobenzylguanidine and Behavior Disorder, Rapid Eye Movement Sleep
Article | Year |
---|---|
Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Humans; Hypotension, Orthostatic; Intermediate Filaments; Parkinson Disease; REM Sleep Behavior Disorder | 2021 |
Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
Topics: 3-Iodobenzylguanidine; Brain; Humans; Parkinson Disease; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2022 |
Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
Topics: 3-Iodobenzylguanidine; Humans; Lewy Body Disease; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Sympathectomy; Tomography, Emission-Computed, Single-Photon; Tropanes | 2022 |
Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up.
Topics: 3-Iodobenzylguanidine; Dopamine; Follow-Up Studies; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder | 2022 |
Idiopathic rapid eye movement sleep behavior disorder in Japan: An observational study.
Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Biomarkers; Cross-Sectional Studies; Dopamine Plasma Membrane Transport Proteins; Humans; Japan; Parkinson Disease; Prospective Studies; REM Sleep Behavior Disorder; Synucleinopathies | 2022 |
Dual-phase
Topics: 3-Iodobenzylguanidine; Dopamine Plasma Membrane Transport Proteins; Glucosylceramidase; Humans; Hypotension, Orthostatic; Mutation; Parkinson Disease; Positron-Emission Tomography; Radionuclide Imaging; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon; Tropanes | 2023 |
Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Humans; Intermediate Filaments; Lewy Body Disease; Multiple System Atrophy; Parkinson Disease; REM Sleep Behavior Disorder | 2023 |
Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Risk Factors | 2023 |
Phenoconversion from rapid eye movement sleep behaviour disorder to multiple system atrophy is predicted by abnormal dopamine transporter imaging combined with normal
Topics: 3-Iodobenzylguanidine; Dopamine Plasma Membrane Transport Proteins; Humans; Multiple System Atrophy; Myocardial Perfusion Imaging; REM Sleep Behavior Disorder | 2020 |
Appropriate assessment method of
Topics: 3-Iodobenzylguanidine; Heart; Humans; Iodine Radioisotopes; Lewy Bodies; Myocardial Perfusion Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Retrospective Studies | 2020 |
The role of cardiac
Topics: 3-Iodobenzylguanidine; Dopamine Plasma Membrane Transport Proteins; Humans; Multiple System Atrophy; Myocardial Perfusion Imaging; Radionuclide Imaging; REM Sleep Behavior Disorder | 2020 |
Early diagnosis of prodromal dementia with Lewy bodies using clinical history of probable REM sleep behaviour disorder and cardiac
Topics: 3-Iodobenzylguanidine; Early Diagnosis; Female; Humans; Lewy Body Disease; Male; Radionuclide Imaging; REM Sleep Behavior Disorder | 2021 |
Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Early Diagnosis; Electroencephalography; Electromyography; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2018 |
Cardiac Sympathetic Activity differentiates Idiopathic and Symptomatic Rapid Eye Movement Sleep Behaviour Disorder.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Female; Heart; Humans; Iodine Radioisotopes; Male; Mediastinum; Middle Aged; Narcolepsy; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Sleep, REM; Young Adult | 2018 |
[A case of severe obstructive sleep apnea mimicking REM sleep behavior disorder].
Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Diagnosis, Differential; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Severity of Illness Index; Sleep Apnea, Obstructive; Video Recording | 2019 |
Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Autonomic Nervous System Diseases; Blood Pressure; Female; Heart Rate; Humans; Hypotension, Orthostatic; Logistic Models; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2016 |
Normal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?
Topics: 3-Iodobenzylguanidine; Aged; Cognition Disorders; Constipation; Cost of Illness; Female; Heart; Humans; Hypotension, Orthostatic; Male; Middle Aged; Olfaction Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2017 |
123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive | 2008 |
Subclinical REM sleep behavior disorder and its clinical and research implications.
Topics: 3-Iodobenzylguanidine; Aged; Dopamine Plasma Membrane Transport Proteins; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Risk Factors | 2008 |
Three-year follow-up on the accumulation of cardiac (123)I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Follow-Up Studies; Humans; Male; Myocardial Perfusion Imaging; Myocardium; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2009 |
Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Female; Gated Blood-Pool Imaging; Humans; Male; Parkinson Disease; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2010 |
Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Female; Heart; Humans; Linear Models; Male; Middle Aged; Myocardium; Parkinson Disease; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2010 |
Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
Topics: 3-Iodobenzylguanidine; Aged; Dominance, Cerebral; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Heart; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iodine Radioisotopes; Lewy Body Disease; Male; Neuropsychological Tests; Occipital Lobe; Positron-Emission Tomography; Radionuclide Imaging; REM Sleep Behavior Disorder; Statistics as Topic; Sympathetic Nervous System; Temporal Lobe | 2010 |
Cardiac 123I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2011 |
Authors' reply to the comments of Miyamoto et al. regarding "Cardiac (123)I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorder".
Topics: 3-Iodobenzylguanidine; Female; Heart; Humans; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder | 2011 |
Combined use of cardiac m-i123-iodobenzylguanidine scintigraphy and ¹²³I-fp-cit single photon emission computed tomography in older adults with rapid eye movement sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Humans; Iodine Radioisotopes; Male; Myocardium; Radiopharmaceuticals; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon | 2011 |
Follow-up study of cardiac ¹²³I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Arrhythmias, Cardiac; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; REM Sleep Behavior Disorder | 2011 |
Cardiac denervation precedes nigrostriatal damage in idiopathic rapid eye movement sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Brain; Corpus Striatum; Heart; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Substantia Nigra; Sympathectomy; Tomography, Emission-Computed, Single-Photon; Tropanes | 2012 |
Reduced myocardial 123I-MIBG uptake in a patient with idiopathic rapid eye movement sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Electroencephalography; Electromyography; Electrooculography; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardium; Radionuclide Imaging; REM Sleep Behavior Disorder | 2007 |
Decreased myocardial (123)I-MIBG uptake and impaired facial expression recognition in a patient with REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Emotions; Facial Expression; Humans; Male; Myocardium; Pattern Recognition, Visual; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Smell; Sympathetic Fibers, Postganglionic; Synucleins | 2007 |
Decrease in myocardial 123I-MIBG radioactivity in REM sleep behavior disorder: two patients with different clinical progression.
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Disease Progression; Electrocardiography; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Sympathetic Fibers, Postganglionic | 2008 |